Surgical needle

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a rear, left, and bottom perspective view of a surgical needle;

FIG. 2 is a front elevational view thereof;

FIG. 3 is a rear elevational view thereof;

FIG. 4 is a right side elevational view thereof;

FIG. 5 is a left side elevational view thereof;

FIG. 6 is a top plan view thereof;

FIG. 7 is a bottom plan view thereof; and,

FIG. 8 is a rear, left, bottom perspective view of the surgical needle shown disposed within a holder.

The broken lines in the figures represent portions of the article or environment that form no part of the claimed design.

Claims

The ornamental design for a surgical needle, as shown and described.

Referenced Cited
U.S. Patent Documents
3394704 July 1968 Dery
4128351 December 5, 1978 Kurtz
5041127 August 20, 1991 Troutman
5433728 July 18, 1995 Kim
5478327 December 26, 1995 McGregor
5871487 February 16, 1999 Warner et al.
5891164 April 6, 1999 Dabir
6159233 December 12, 2000 Matsuzawa
6530943 March 11, 2003 Hoepffner
8214996 July 10, 2012 Stametz
8292874 October 23, 2012 Stivland et al.
D691267 October 8, 2013 Marsteller
9259219 February 16, 2016 Maurer
9445837 September 20, 2016 Fulton, III
9827109 November 28, 2017 Steinberg
D837982 January 8, 2019 Adler
10548628 February 4, 2020 Swaney
10688285 June 23, 2020 Marsala et al.
D937417 November 30, 2021 Cichocki, Jr.
D938031 December 7, 2021 Sivaraman
20020042607 April 11, 2002 Palmer et al.
20020082390 June 27, 2002 Friddle et al.
20020095124 July 18, 2002 Palasis et al.
20030069398 April 10, 2003 Rippmann et al.
20030130577 July 10, 2003 Purdy et al.
20030195633 October 16, 2003 Hyde, Jr.
20050085790 April 21, 2005 Guest et al.
20060205999 September 14, 2006 Berger et al.
20070142748 June 21, 2007 Deshmukh et al.
20080051357 February 28, 2008 Chang et al.
20080154262 June 26, 2008 Brundobler et al.
20100004625 January 7, 2010 Boulis
20100023021 January 28, 2010 Flaherty
20100030184 February 4, 2010 Boulis et al.
20100198189 August 5, 2010 Marsala
20120221063 August 30, 2012 Abdou
20130211380 August 15, 2013 Aquino et al.
20140058357 February 27, 2014 Keyser et al.
20140073684 March 13, 2014 Stoffel et al.
20140256801 September 11, 2014 Glorioso et al.
20150224331 August 13, 2015 Marsala
20150343038 December 3, 2015 Marsala
20160081956 March 24, 2016 Kaufman et al.
20180008727 January 11, 2018 Marsala
20180117282 May 3, 2018 Marsala et al.
20190071486 March 7, 2019 Marsala
Foreign Patent Documents
101528922 September 2009 CN
103328038 September 2013 CN
1994/10988 May 1994 WO
2004/060464 July 2004 WO
WO-2006/047554 May 2006 WO
2008/112177 September 2008 WO
2010/071832 June 2010 WO
2011/057171 May 2011 WO
2012/075337 June 2012 WO
2014/047540 March 2014 WO
2014/116652 July 2014 WO
2014/184576 November 2014 WO
2016/122791 August 2016 WO
WO-2017/172606 October 2017 WO
Other references
  • Bu et al. “Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene,” Proc. Natl. Acad. Sci. USA, Mar. 1992, 89:2115-2119.
  • Chaudhry et al. “The Vesicular GABA Transporter, VGAT, Localizes to Synaptic Vesicles in Sets of Glycinergic as Well as GABAergic Neurons,” The Journal of Neuroscience, Dec. 1, 1998, 18(23):9733-9750.
  • PCT/US2020/013059 International Search Report and Written Opinion dated Apr. 1, 2020.
  • Poston et al. “Catheter delivery systems for infusions into the cortex,” Journal of Medical Engineering & Technology, Jul. 2011, 35(5):246-253.
  • Kantor et al. “Clinical Applications Involving CNS Gene Transfer,” Adv Genet., 2014, 87:71-124.
  • Bouard et al. “Viral vectors: from virology to transgene expression,” British Journal of Pharmacology, 2009, 157:153-165.
  • Adkins et al. “Tiagabine: A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Potential in the Management of Epilepsy,” Drugs, Mar. 1998, 55(3):437-460.
  • Gholizadeh et al. “Transduction of the Central Nervous System After Intracerebroventricular Injection of Adeno-Associated Viral Vectors in Neonatal and Juvenile Mice,” Human Gene Therapy Methods, Aug. 2013, 24:205-213.
  • EP14742941 Extended European Search Report dated Jun. 20, 2016.
  • Dayton et al. “The advent of AAV9 expands applications for brain and spinal cord gene delivery,” Expert Opinion on Biological Therapy, Jun. 15, 2012, 12(6):757-766.
  • Federici et al. “Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs,” Gene Therapy, 2012, 19(8):852-859.
  • Foust et al. “Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes,” Nature Biotechnology, Jan. 2009, 27(1):59-65.
  • Hirai et al. “Intrathecal shRNA-AAV9 Inhibits Target Protein Expression in the Spinal Cord and Dorsal Root Ganglia of Adult Mice,” Human Gene Therapy Methods, Apr. 1, 2012, 23(2):119-127.
  • Kakinohana et al. “Combinational Spinal GAD65 Gene Delivery and Systemic GABA-Mimetic Treatment for Modulation of Spasticity,” PloS One, Jan. 2012, 7(1):e30561.
  • PCT/US2017/024285 International Search Report and Written Opinion dated Aug. 10, 2017.
  • Jin et al. “Demonstration of Functional Coupling between Gamma-Aminobutyric acid (GABA) Synthesis and Vesicular GABA Transport into Synaptic Vesicles,” Proc Natl Acad Sci USA, Apr. 2003, 100(7):4293-4298.
  • EP15880645 Extended European Search Report dated May 24, 2018.
  • Colak et al. “Adenovirus-mediated gene therapy for experimental spinal cord tumors: tumoricidal efficacy and functional outcome,” Brain Research, May 1995, 691:76-82.
  • JP2017-540569 Office Action dated Jun. 26, 2018.
  • PCT/US2015/065704 International Search Report dated Feb. 25, 2016.
  • CN201580078566.9 Office Action dated Sep. 24, 2019.
  • JP2017-540569 Office Action dated Jun. 4, 2019.
  • Bell et al. “Motor Neuron Transduction After Intracisternal Delivery of AAV9 in a Cynomolgus Macaque,” Human Gene Therapy Methods, Apr. 2015, 26:43-44.
  • Duque et al. “Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons,” Molecular Therapy, Jul. 2009, 17(7):1187-1196.
  • Foust et al. “Therapeutic AAV9-mediated Suppression of Mutant SOD1 Slows Disease Progression and Extends Survival in Models of Inherited ALS,” Molecular Therapy, Dec. 2013, 21(12):2148-2159.
  • Gray et al. “Preclinical Differences of Intravascular AAV9 Delivery to Neurons and Glia: A Comparative Study of Adult Mice and Nonhuman Primates,” Molecular Therapy, Jun. 2011, 19(6):1058-1069.
  • Kakinohana et al. “Region-specific cell grafting into cervical and lumbar spinal cord in rat: a qualitative and quantitative stereological study,” Experimental Neurology, 2004, 190:122-132.
  • Meyer et al. “Improving Single Injection CSF Delivery of AAV9-mediated Gene Therapy for SMA: A Dose-response Study in Mice and Nonhuman Primates, Molecular Therapy,” Mar. 2015, 23(3):477-487.
  • Passini et al. “Translational Fidelity of Intrathecal Delivery of Self-Complementary AAV9-Survival Motor Neuron 1 for Spinal Muscular Atrophy,” Human Gene Therapy, Jul. 2014, 25:619-630.
  • Usvald et al. “Analysis of Dosing Regimen and Reproducibility of Intraspinal Grafting of Human Spinal Stem Cells in Immunosuppressed Minipigs,” Cell Transplantation, 2010, 19:1103-1122.
  • Xiao et al. “Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus,” Journal of Virology, Mar. 1998, 72(3):2224-2232.
  • Xu et al. In Vivo Gene Knockdown in Rat Dorsal Root Ganglia Mediated by Self-Complementary Adeno-Associated Virus Serotype 5 Following Intrathecal Delivery, PLoS One, Mar. 2012, 7(3):e32581.
  • CN201580078566.9 Office Action dated Apr. 28, 2020.
  • PCT/US2018/049914 International Search Report and Written Opinion dated Nov. 21, 2018.
  • “H.sapiens mRNA for glutamate decarboxylase, GenBank: X69936.1,” GenBank, Mar. 16, 1993 [Retrieved from the Internet: https://www.ncbi.nlm.nih.gov/nuccore/X69936].
  • EP17776384.4 Extended European Search Report dated Jul. 31, 2019.
  • Kitzman, Patrick. “Changes in vesicular glutamate transporter 2, vesicular GABA transporter and vesicular acetylcholine transporter labeling of sacrocaudal motoneurons in the spastic rat,” Experimental Neurology, 2006, 197:407-419.
Patent History
Patent number: D963164
Type: Grant
Filed: Jan 9, 2020
Date of Patent: Sep 6, 2022
Assignee: The Regents of the University of California (Oakland, CA)
Inventor: Martin Marsala (Solana Beach, CA)
Primary Examiner: David G Muller
Application Number: 29/720,014